[go: up one dir, main page]

AU5065098A - Modulators of ovarial apoptosis related to iap - Google Patents

Modulators of ovarial apoptosis related to iap

Info

Publication number
AU5065098A
AU5065098A AU50650/98A AU5065098A AU5065098A AU 5065098 A AU5065098 A AU 5065098A AU 50650/98 A AU50650/98 A AU 50650/98A AU 5065098 A AU5065098 A AU 5065098A AU 5065098 A AU5065098 A AU 5065098A
Authority
AU
Australia
Prior art keywords
ovarial
iap
modulators
apoptosis related
apoptosis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU50650/98A
Inventor
Robert G. Korneluk
Benjamin K. Tsang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Ottawa
Original Assignee
University of Ottawa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Ottawa filed Critical University of Ottawa
Publication of AU5065098A publication Critical patent/AU5065098A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4873—Cysteine endopeptidases (3.4.22), e.g. stem bromelain, papain, ficin, cathepsin H

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Zoology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU50650/98A 1996-11-15 1997-11-14 Modulators of ovarial apoptosis related to iap Abandoned AU5065098A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US3093196P 1996-11-15 1996-11-15
US60030931 1996-11-15
PCT/IB1997/001506 WO1998022131A2 (en) 1996-11-15 1997-11-14 Modulators of ovarial apoptosis related to iap

Publications (1)

Publication Number Publication Date
AU5065098A true AU5065098A (en) 1998-06-10

Family

ID=21856757

Family Applications (1)

Application Number Title Priority Date Filing Date
AU50650/98A Abandoned AU5065098A (en) 1996-11-15 1997-11-14 Modulators of ovarial apoptosis related to iap

Country Status (2)

Country Link
AU (1) AU5065098A (en)
WO (1) WO1998022131A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115843929A (en) * 2020-09-02 2023-03-28 青岛隆和生物科技有限公司 Application of composite polypeptide feed in regulating and controlling chicken ovarian granular cells

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5958771A (en) * 1998-12-03 1999-09-28 Isis Pharmaceuticals, Inc. Antisense modulation of cellular inhibitor of Apoptosis-2 expression
US6087173A (en) * 1999-09-09 2000-07-11 Isis Pharmaceuticals Inc. Antisense modulation of X-linked inhibitor of apoptosis expression
US6156535A (en) 1995-08-04 2000-12-05 University Of Ottawa Mammalian IAP gene family, primers, probes, and detection methods
US6133437A (en) 1997-02-13 2000-10-17 Apoptogen, Inc. Modulation of IAPs for the treatment of proliferative diseases
US6171821B1 (en) * 1998-07-24 2001-01-09 Apoptogen, Inc. XIAP IRES and uses thereof
US6472172B1 (en) * 1998-07-31 2002-10-29 Schering Aktiengesellschaft DNA encoding a novel human inhibitor-of-apoptosis protein
AU5544500A (en) * 1999-06-15 2001-01-02 Astrazeneca Ab Livin; inhibitor-of-apoptosis protein-3 (iap-3)
US6673917B1 (en) 2000-09-28 2004-01-06 University Of Ottawa Antisense IAP nucleic acids and uses thereof
US7091333B2 (en) 2002-03-27 2006-08-15 Aegera Therapeutics, Inc. Antisense IAP nucleobase oligomers and uses thereof
US8012944B2 (en) 2003-10-30 2011-09-06 Pharmascience Inc. Method for treating cancer using IAP antisense oligomer and chemotherapeutic agent
WO2015109391A1 (en) 2014-01-24 2015-07-30 Children's Hospital Of Eastern Ontario Research Institute Inc. Smc combination therapy for the treatment of cancer
CN104164418A (en) * 2014-06-26 2014-11-26 北京圣谷同创科技发展有限公司 Paraffin-embedded tissue slice genome DNA extraction kit and using method thereof
CN115976021B (en) * 2022-09-26 2025-12-19 新疆农业大学 LncRNA MSTRG.5970.28 and application thereof, and products and methods for regulating ovarian development

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK49987A (en) * 1987-01-30 1988-07-31 Nordisk Gentofte PROCEDURE FOR TREATING INFERTILITY AND METHOD FOR USING THE PROCEDURE
CA2220670A1 (en) * 1995-05-11 1996-11-14 Peter L. Hudson Human inhibitor of apoptosis gene 1

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115843929A (en) * 2020-09-02 2023-03-28 青岛隆和生物科技有限公司 Application of composite polypeptide feed in regulating and controlling chicken ovarian granular cells

Also Published As

Publication number Publication date
WO1998022131A3 (en) 1998-07-30
WO1998022131A2 (en) 1998-05-28

Similar Documents

Publication Publication Date Title
PL331385A1 (en) Diphenyletherocycles as modulators of potassium canals
AU690163B2 (en) Antimigraine derivatives of indolylcycloalkanylamines
AU5710398A (en) Thiazole compounds and methods of modulating signal transduction
AU6024196A (en) Inspection of edges
AU1905999A (en) Method to identify transcriptional modulators
AU5065098A (en) Modulators of ovarial apoptosis related to iap
AU5785296A (en) Face shield
AU2232597A (en) Method of screening apoptosis inducing substances
AU5270598A (en) Single sideband modulators
AU3209993A (en) Frequency domain polarimeter
AU6692996A (en) Inhibitors of apoptosis
AU4944297A (en) Modulation of apoptosis
AU6143998A (en) Regulators of apoptosis
AU2557097A (en) Enhanced expression of transgenes
AU2154597A (en) Packaging for two or more substances to be mixed together
AU6133196A (en) Improvements relating to sighting devices
AU4595497A (en) Addition of color to electrochromic displays
AU5065698A (en) Improvements to gas-masks
AU3120797A (en) Structured glycerols and structured phosphatides
AU2624797A (en) Balanced modulator
AU4931697A (en) Operation of optical modulators
AU5233799A (en) Modulation of apoptosis with bid
AU2462895A (en) Enhancing the sensitivity of tumor cells to therapies
AU3338097A (en) Improvements relating to bleaching compositions
AU5657596A (en) Composition of matter